Building the In Vivo Future: What Lilly’s Kelonia Bet Really Signals
By Amith Chordia and John Barry. Eli Lilly’s recent acquisition of Kelonia raised eyebrows, not because of what’s proven, but […]
By Amith Chordia and John Barry. Eli Lilly’s recent acquisition of Kelonia raised eyebrows, not because of what’s proven, but […]
SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group December 3, 2025 Reading, PA SAI